Trials / Withdrawn
WithdrawnNCT00594334
Effect of Actonel on Periodontal Health of Postmenopausal Women
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University Hospitals Cleveland Medical Center · Academic / Other
- Sex
- Female
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
Hypothesis: Women who use Actonel (risedronate) for osteopenia will show beneficial periodontal effects.
Detailed description
Women who use Actonel for osteopenia will show beneficial attachment loss, alveolar bone height and morphology as compared to those who do not when oral hygiene is corrected for.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Risedronate | Weekly Risedronate |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-01-01
- Completion
- 2011-01-01
- First posted
- 2008-01-15
- Last updated
- 2022-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00594334. Inclusion in this directory is not an endorsement.